期刊文献+

生长激素在肝纤维化患者中的应用 被引量:2

Application of growth hormone therapy in patients with liver cirrhosis
下载PDF
导出
摘要 生长激素不但能在生长过程中起重要作用,而且在碳水化合物,脂类代谢过程中起重要作用。慢性肝病的一个重要特征是生长激素抵抗现象,其表现为血清中生长激素的浓度较高而胰岛素样生长因子-1的水平降低。使用生长激素治疗慢性肝病,可提高患者血清中胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3升高,改善患者的生长激素抵抗现象,改善肝功能,纠正低蛋白血症。该文就使用生长激素治疗慢性肝病和肝纤维化的研究现状做一简要综述。 Growth hormone is important not only in growth action,but also in very wide fields,such as carbohydrate and lipid metabolism.Chronic liver cirrhosis is characterized as one of the growth hormone resistant states,whereby GH serum levels are high in the presence of low insulin-like growth factor-1 serum levels.Insulin-like growth factor-I and insulin-like growth factor binding protein-3 concentrations is increased in human growth hormone treated patients.Growth hormone can improve liver function effectively,prevent growth hormone resistant states,increase serum albumin concentration in patients with chronic liver disease and cirrhosis.The present situation concerning the therapeutic effect of growth hormone therapy in patients with chronic liver disease and cirrhosis is reviewed.
作者 李瑞麟 杨芳
出处 《安徽医药》 CAS 2012年第5期689-692,共4页 Anhui Medical and Pharmaceutical Journal
关键词 生长激素 胰岛素样生长因子 肝纤维化 growth hormone insulin-like growth factor liver cirrhosis
  • 相关文献

参考文献5

二级参考文献19

  • 1闵佳,丁惠国,闫惠萍,贺丽香,刘惠珍,赵春惠.重型病毒性肝炎患者生长激素-胰岛素样生长因子轴的临床研究[J].中华肝脏病杂志,2001,9(S1):76-78. 被引量:14
  • 2Shi Jie Wang,Deng Gui Wen,Jing Zhang,Xin Man,Hui Liu Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.Intensify standardized therapy for esophageal and stomach cancer in tumor hospitals[J].World Journal of Gastroenterology,2001,7(1):80-82. 被引量:9
  • 3Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 4梁力建,罗时敏,胡文杰.氨基酸溶液和重组人生长激素对肝硬化大鼠生长激素-胰岛素样生长因子1轴的影响[J].中华外科杂志,2005,43(11):697-701. 被引量:6
  • 5Ellegard L,Bosaeus L,Nordgren S,et al.Lowdose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome[J].Ann Surg,1997,225(1):88 96.
  • 6王洪涛 陈双 等.实验性肝硬化过程中生长激素受体的动态变化[J].中国实用外科杂志,1999,19:58-58.
  • 7Ross RJ. GH, IGF and binding proteins in altered nutritional states. Int J Obes Relat Metab Disord, 2000, 24(Suppl 2) : S92-S95.
  • 8Ali O, Cohen P, Lee KW. Epidemiology and biology of insulin-like growth factor binding protein-3 ( IGFBP-3 ) as an anti-cancer molecule. Horm Metab Res, 2003,35(11-12) : 726-733.
  • 9Aihara T, Noguchi S, Miyoshi Y, et al. Allelic imbalance of insulin-like growth factor Ⅱ gene expression in cancerous and precancerous lesions of the liver. Hepatology, 1998,28( 1 ) : 86-89.
  • 10Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Ontology, 2002, 63(4): 317- 322.

共引文献35

同被引文献28

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部